二甲双胍盐酸盐和钼酸铵等具备较大的生产能力，具有较高市场份额。
Metformin hydrochloride and ammonium molybdate are retaining high producing power and market shares, there are the other tens kinds of medicine intermediates on researching .
方法用紫外分光光度法测定该制剂中盐酸二甲双胍的含量，高效液相色谱法测定格列吡嗪的含量。
Methods The content of dimethydiguanide was determined by ultraviolet spectrophotometry, and the content of glipizide was determined by high-performance liquid chromatography(HPLC).
结论：本方法准确、快速、简便，可不经分离直接测定复方盐酸二甲双胍片中盐酸二甲双胍的含量。
CONCLUSION: the method is accurate, fast, convenient, and which can be used to determine the contents of metformin hydrochloride in compound metformin hydrochloride tablets directly without isolation.
盐酸二甲双胍是目前广泛用于临床医学的双胍类降糖药。
Metformin hydrochloride is an orally administered biguanide widely used in clinical medicine.
优选由那格列奈速释层与盐酸二甲双胍缓释层组成的双层片处方。
To optimize the formula of the double-layer tablet of nateglinide rapid-release layer and metformin hydrochloride sustained-release layer.
目的对盐酸二甲双胍缓释片体外释放度相关因素进行研究。
Objective to study on the factors involved in the release rate of metformin hydrochloride in vitro sustained-release tablets.
结论本释放度方法简单，快速，可用于盐酸二甲双胍缓释片体外释放度测定。
Conclusions the determination method is simple and swift, and can be applied in the determination of in vitro release rate of metformin hydrochloride sustained-release tablets.
制备膜控释盐酸二甲双胍缓释片并对其体外释放度的相关影响因素进行研究。
The membrane controlled-release coated tablets of metformin hydrochloride were prepared by coating method and the factors involved in the release rate of metformin hydrochloride in vitro were studied.
本文采用流化床技术制备盐酸二甲双胍素丸，并采用缓释包衣材料制备缓释盐酸二甲双胍微丸。
In this thesis, Metformin Hydrochloride pellets and sustained-release pellets were prepared by powder coating technology.
本发明为化学合成领域的盐酸二甲双胍精制方法。
The invention provides a method for refining metformin hydrochloride in the technical field of chemical synthesis.
得到的盐酸二甲双胍 的澄清度合格，合格率为100％，符合要求。
The obtained metformin hydrochloride is qualified in clarity with a qualification rate of 100 percent, and satisfies requirement.
本发明公开了一种双胍类抗糖尿病药物，特别是盐酸二甲双胍的肠溶药物组合物。
The invention discloses a biguanide anti-diabetes medicine, in particular to a metformin hydrochloride enteric-coated medicine compound.
缓释制剂中格列吡嗪和盐酸二甲双胍的重量比范围1∶100至1∶200，最优比例为1∶100，制剂中加入适量药用辅料。
The weight ratio of glipizide to metformin hydrochloride is 1 : 100-200, the best ratio is 1:100 and it adds a proper amount of medicinal auxiliary to the preparation.
目的：研制复方盐酸二甲双胍缓释胶囊，并对盐酸二甲双胍(MH)和格列美脲进行释放度研究。
Objective: To prepare compound metformin hydrochloride sustained-release capsules, and investigate the release behavior of metformin hydrochloride (MH) and glimepiride.
目的探讨盐酸二甲双胍缓释片治疗2型糖尿病患者的临床效果和安全性。
Metformin hydrochloride sustained-release tablets and rosiglitazone maleate tablets in the treatment of type 2 diabetes.
目的探讨盐酸二甲双胍缓释片治疗2型糖尿病患者的临床效果和安全性。
Metformin hydrochloride sustained-release tablets and rosiglitazone maleate tablets in the treatment of type 2 diabetes.
应用推荐